We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.29%
This Fund
S&P 500
This Quarter Est. Return
+5.34%
1 Year Est. Return
+106.29%
3 Year Est. Return
+266.67%
5 Year Est. Return
+310.43%
10 Year Est. Return
+1,579.99%
AUM
$4.32B
AUM Growth
+$316M
Cap. Flow
-$173M
Cap. Flow %
-4%
Top 10 Hldgs %
10.31%
Holding
2,841
New
651
Increased
541
Reduced
445
Closed
892

Sector Composition

Rank Sector Weight
1 Financials 12.96%
2 Healthcare 8.24%
3 Technology 8.23%
4 Industrials 6.13%
5 Consumer Discretionary 5.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZVIA icon
1751
Zevia
ZVIA
$111M
$97K ﹤0.01%
+23,713
New +$97.8K
GRTS
1752
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$97K ﹤0.01%
+28,110
New +$80.3K
ALLK
1753
DELISTED
Allakos
ALLK
$97K ﹤0.01%
+11,515
New +$80K
BMEA icon
1754
Biomea Fusion
BMEA
$92.1M
$96K ﹤0.01%
+11,385
New +$97.1K
OMGA
1755
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$95.3K ﹤0.01%
+16,683
New +$93.6K
MRNS
1756
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$95.2K ﹤0.01%
+23,927
New +$118K
VOR icon
1757
Vor Biopharma
VOR
$1.3B
$95.2K ﹤0.01%
+716
New +$70.8K
XAIR icon
1758
Beyond Air
XAIR
$3.96M
$94.8K ﹤0.01%
+37
New +$94.7K
LENZ
1759
LENZ Therapeutics
LENZ
$167M
$94.5K ﹤0.01%
+4,066
New +$94.2K
ARAY icon
1760
Accuray
ARAY
$37.3M
$94.3K ﹤0.01%
+45,107
New +$93.2K
ALDX icon
1761
Aldeyra Therapeutics
ALDX
$94.7M
$94.1K ﹤0.01%
+13,525
New +$77.3K
CLPT icon
1762
ClearPoint Neuro
CLPT
$435M
$93.8K ﹤0.01%
+11,074
New +$105K
MCAGR
1763
DELISTED
Mountain Crest Acquisition Corp. V Right
MCAGR
$93.6K ﹤0.01%
450,000
VYGR icon
1764
Voyager Therapeutics
VYGR
$191M
$92.7K ﹤0.01%
+15,203
New +$86.4K
INFU icon
1765
InfuSystem Holdings
INFU
$234M
$92.5K ﹤0.01%
+10,654
New +$86.8K
VMD icon
1766
Viemed Healthcare
VMD
$365M
$92.4K ﹤0.01%
+12,227
New +$82.8K
CVGI icon
1767
Commercial Vehicle Group
CVGI
$150M
$92.3K ﹤0.01%
+13,555
New +$79K
PANL icon
1768
Pangaea Logistics
PANL
$477M
$92.1K ﹤0.01%
17,886
-62,114
-78% -$307K
ONFOW icon
1769
Onfolio Holdings Warrant
ONFOW
$74.5K
$91.2K ﹤0.01%
60,000
RENT
1770
Rent the Runway
RENT
$123M
$91K ﹤0.01%
+1,492
New +$60.6K
GATO
1771
DELISTED
Gatos Silver, Inc.
GATO
$90.9K ﹤0.01%
+22,214
New +$80.7K
PSTX
1772
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$90.9K ﹤0.01%
+17,142
New +$78.4K
ZUO
1773
DELISTED
Zuora, Inc.
ZUO
$90.7K ﹤0.01%
14,267
-19,052
-57% -$135K
LUNA
1774
DELISTED
Luna Innovations Incorporated
LUNA
$90.4K ﹤0.01%
10,283
-119,838
-92% -$760K
BKSY icon
1775
BlackSky Technology
BKSY
$1.19B
$90.4K ﹤0.01%
+7,336
New +$97.6K

Similar funds

Boothbay Fund Management's Q4 2022 Portfolio in Review

As of Q4 2022, Boothbay Fund Management held 2,841 positions worth $4.32B, up 7.9% from $4.01B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Boothbay Fund Management withdrew a net $173M in Q4 2022, closing 892 positions and reducing 445 holdings. Its most notable exit was Alleghany Corp, an estimated $20.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Boothbay Fund Management opened a new position in Kairos Acquisition Corp. Class A Ordinary Shares worth $12.6M.

  • Boothbay Fund Management's largest Q4 2022 buy was Kairos Acquisition Corp. Class A Ordinary Shares: 1,255,444 shares worth $12.6M.
  • Boothbay Fund Management added most to RMG Acquisition Corp. III Class A Ordinary Shares in Q4 2022, an estimated $19.5M increase.
  • Boothbay Fund Management's biggest Q4 2022 reduction was ADMA Biologics, cutting an estimated $21.8M.
  • Boothbay Fund Management fully exited Alleghany Corp in Q4 2022, selling an estimated $20.1M.
  • Boothbay Fund Management's ten largest holdings make up 10% of its $4.32B portfolio in Q4 2022.
  • Boothbay Fund Management opened 651 new positions and closed 892 in Q4 2022.
  • Boothbay Fund Management's portfolio value rose 7.9% quarter-over-quarter to $4.32B.

Based on Boothbay Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.